Holles Natalie C.

CIK 00015801116 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001580111

Recent Transactions

50 trades

Award
Day One Biopharmaceuticals, Inc.$DAWN
Stock Option (right to buy Common Stock)
2024-05-23+32,335→ 32,335 total
Exercise/Conversion
Third Harmonic Bio, Inc.
Employee Stock Option (right to buy)
2024-05-09−20,222→ 433,854 total
Exercise/Conversion
Third Harmonic Bio, Inc.
Common Stock
2024-05-09$4.20/sh+20,222→ 1,239,058 total
Sale
Third Harmonic Bio, Inc.
Common Stock
2024-05-09$12.18/sh−20,222→ 1,218,836 total
Sale
Third Harmonic Bio, Inc.
Common Stock
2024-04-11$12.19/sh−13,558→ 1,218,836 total
Exercise/Conversion
Third Harmonic Bio, Inc.
Common Stock
2024-04-11$4.20/sh+13,558→ 1,232,394 total
Exercise/Conversion
Third Harmonic Bio, Inc.
Employee Stock Option (right to buy)
2024-04-11−13,558→ 454,076 total
Award
Third Harmonic Bio, Inc.
Employee Option Grant (right to buy)
2024-01-05+396,000→ 396,000 total
Award
Third Harmonic Bio, Inc.
Employee Option Grant (right to buy)
2024-01-05+396,000→ 396,000 total
Award
Day One Biopharmaceuticals, Inc.$DAWN
Director Stock Option (Right to buy Common Stock)
2023-06-22+37,500→ 37,500 total
Award
Third Harmonic Bio, Inc.
Employee Stock Option (right to buy)
2023-03-06+205,000→ 205,000 total
Award
Third Harmonic Bio, Inc.
Employee Stock Option (right to buy)
2023-03-06+467,634→ 467,634 total
Disposition to Issuer
Third Harmonic Bio, Inc.
Employee Stock Option (right to buy)
2023-03-06−205,000→ 0 total
Award
Third Harmonic Bio, Inc.
Employee Stock Option (right to buy)
2023-03-06+360,000→ 360,000 total
Disposition to Issuer
Third Harmonic Bio, Inc.
Employee Stock Option (right to buy)
2023-03-06−467,634→ 0 total
Award
Third Harmonic Bio, Inc.
Employee Option Grant (right to buy)
2022-10-25+205,000→ 205,000 total
Award
Day One Biopharmaceuticals, Inc.$DAWN
Director Stock Option (Right to buy Common Stock)
2022-06-21+28,700→ 28,700 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2022-05-12+25,000→ 25,000 total
Award
Allakos Inc.
Stock Option (Right to buy)
2021-05-25+7,700→ 7,700 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2021-05-12+25,000→ 25,000 total
Award
Allakos Inc.
Stock Option (Right to buy)
2021-01-04+4,000→ 4,000 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-21+25,000→ 25,000 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−25,000→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−548→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−110,703→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−93,109→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−50,105→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−40,883→ 0 total
Disposition from Tender
Audentes Therapeutics, Inc.
Common Stock
2020-01-15$60.00/sh−104,439→ 0 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-12-12$9.50/sh+5,715→ 97,464 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-12-12$2.76/sh+45,726→ 91,749 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-12-12−74,117→ 40,883 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-12-12−14,895→ 50,105 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-12-12−45,726→ 110,703 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-12-12$59.37/sh−8,681→ 46,023 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-12-12$15.26/sh+74,117→ 171,581 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common stock
2019-12-12$27.39/sh+6,891→ 178,472 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-12-12$59.37/sh−88,928→ 104,439 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-12-12−6,891→ 93,109 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-12-12$24.74/sh+14,895→ 193,367 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-12-12−5,715→ 548 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-12-05$59.21/sh−505→ 54,704 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-09-05$31.02/sh−505→ 55,209 total
Tax Payment
Audentes Therapeutics, Inc.
Common Stock
2019-06-05$37.31/sh−1,009→ 55,714 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2019-03-29+50,000→ 50,000 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-02-06+65,000→ 65,000 total
Award
Audentes Therapeutics, Inc.
Common Stock
2019-02-06+23,333→ 56,723 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Common Stock
2019-01-24$2.76/sh+8,300→ 33,390 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-01-24−8,300→ 156,429 total
Exercise/Conversion
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2018-06-01−5,090→ 164,729 total

Companies

Recent Filings

Address

C/O AUDENTES THERAPEUTICS, INC. 600 CALIFORNIA STREET, 17TH FLOOR

SAN FRANCISCO, CA, 94108

View on SEC.gov